Biopharmaceutical Stock Blasts Higher on Alzheimer's Treatment Update

Options traders are rushing to the stock amid annual highs

Deputy Editor
Aug 31, 2021 at 10:51 AM
facebook X logo linkedin


The shares of Switzerland-based biopharmaceutical company AC Immune SA (NASDAQ:ACIU) are soaring this morning, up 72.4% to trade at $12.04 at last check. The company announced that Genentech, a unit of its partner, Roche Holding AG, reported that its experimental Alzheimer's disease (AD) therapy met one of two main goals in its Phase 2 study. The tau-targeting monoclonal antibody, Semorinemab, is being developed in collaboration with AC Immune SA. 

Earlier in the session, ACUI touched a new fresh annual high of $12.61, toppling it previous Feb. 18 peak of $12.50, though it appears that level could act as a ceiling. Meanwhile, the $6 level has been a line of consistent support over the past few months, and today's bull gap has the equity blasting past pressure at the 140-day moving average. Year-to-date, the stock is up 136.6%.

Analysts are bullish on ACIU, with all three in coverage carrying a "strong buy" rating. Plus, the 12-month consensus price target of $15.17 is a 33% premium to current levels. 

ACIU's typically quiet options pits are bursting with activity today, with options volume running at 392 times what's typically seen at this point, and pacing for the top percentile of its annual range. More specifically, 3,355 calls and 2,932 puts have crossed the tape. The September 15 call is the most popular, followed by the September 7.50 put, with new positions being opened at both. 

 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI